Fierce Biotech

1. Aduro, Chinook ink merger to take renal drug into phase 3 

   Aduro, Chinook ink merger to take renal drug into phase 3  ntaylor Wed, 06/03/2020 - 08:21

2. In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center

   In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center badams Tue, 06/02/2020 - 08:53

3. Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority

   Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority ntaylor Tue, 06/02/2020 - 08:22

4. Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis

   Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis badams Tue, 06/02/2020 - 07:07

5. Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs

   Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs badams Tue, 06/02/2020 - 04:33